Analyst Consensus
|
FY25 Actual £m |
FY26 Consensus £m |
FY27 Consensus £m |
FY28 Consensus £m |
|
|---|---|---|---|---|
Total Sales |
375.3 |
402.1 |
435.1 |
473.3 |
UK |
108.4 |
107.3 |
106.9 |
107.2 |
US |
131.9 |
152.5 |
178.8 |
208.5 |
Europe |
97.3 |
101.9 |
105.2 |
109.3 |
ROW |
37.7 |
40.4 |
44.2 |
48.3 |
EBITDA |
42.4 |
50.4 |
64.2 |
78.0 |
PBT |
29.9 |
40.4 |
54.7 |
68.2 |
Normalised EPS (p) |
24.12 |
29.5 |
39.0 |
49.1 |
Analyst Consensus
The consensus data was last updated on 7/05/2026.
The Full Year consensus is calculated by taking the simple average of submissions from registered investment analysts who cover Fever-Tree, based on their opinions, forecasts, estimates, projections and predictions regarding the Company's performance. It does not represent the Company’s own views on its performance, nor does the Company or its management endorse or make any representation or warranty in relation to the consensus data. The Company endeavours to ensure that the consensus data, which is sourced from Visible Alpha, is accurate and up-to-date but it is not under an obligation to update the consensus data.
Our STRATEGY
Related PAGES
